 | • レポートコード：GIR-2104Z10725 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ペプチド・ヘパリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ペプチド・ヘパリンの種類別市場規模（インスリン、テリパラチド、リラグルチド、リュープロリド、リュープロリド、エクセナチド、カルシトニン、エナキサパリンナトリウム、ヘパリンナトリウム）、用途別市場規模（糖尿病、感染症、がん、骨粗鬆症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ペプチド・ヘパリンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Cipla Ltd.、Emcure Pharmaceuticals Pvt. Ltd.、Gland Pharma Limited、Troikaa Pharmaceuticals Ltd.、Biological E Limited、Bharat Biotech、Samarth Life Sciences Pvt. Ltd.、VHB Life Sciences Limited、Celon Laboratories Pvt. Ltd.、United Biotech (P) Limited、Biocon Limited、Sun Pharmaceutical Industries Ltd.、Wockhardt Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：インスリン、テリパラチド、リラグルチド、リュープロリド、リュープロリド、エクセナチド、カルシトニン、エナキサパリンナトリウム、ヘパリンナトリウム ・用途別分析2016年-2026年：糖尿病、感染症、がん、骨粗鬆症 ・ペプチド・ヘパリンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ペプチド・ヘパリンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ペプチド・ヘパリンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ペプチド・ヘパリンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ペプチド・ヘパリンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Peptides and Heparin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Peptides and Heparin size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Peptides and Heparin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Peptides and Heparin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Insulin
Teriparatide
Liraglutide
Leuprolide
Leuprolide
Exenatide
Calcitonin
Enaxaparin Sodium
Heparin Sodium
Market segment by Application can be divided into
Diabetes
Infectious Diseases
Cancer
Osteoporosis
The key market players for global Peptides and Heparin market are listed below:
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech (P) Limited
Biocon Limited
Sun Pharmaceutical Industries Ltd.
Wockhardt Ltd.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Peptides and Heparin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peptides and Heparin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Insulin
1.2.3 Teriparatide
1.2.4 Liraglutide
1.2.5 Leuprolide
1.2.6 Leuprolide
1.2.7 Exenatide
1.2.8 Calcitonin
1.2.9 Enaxaparin Sodium
1.2.10 Heparin Sodium
1.3 Market Analysis by Application
1.3.1 Overview: Global Peptides and Heparin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Cancer
1.3.5 Osteoporosis
1.4 Global Peptides and Heparin Market Size & Forecast
1.4.1 Global Peptides and Heparin Sales in Value (2016-2026))
1.4.2 Global Peptides and Heparin Sales in Volume (2016-2026)
1.4.3 Global Peptides and Heparin Price by Type (2016-2026) & (USD/MT)
1.5 Global Peptides and Heparin Production Capacity Analysis
1.5.1 Global Peptides and Heparin Total Production Capacity (2016-2026)
1.5.2 Global Peptides and Heparin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Peptides and Heparin Market Drivers
1.6.2 Peptides and Heparin Market Restraints
1.6.3 Peptides and Heparin Trends Analysis
2 Manufacturers Profiles
2.1 Cipla Ltd.
2.1.1 Cipla Ltd. Details
2.1.2 Cipla Ltd. Major Business
2.1.3 Cipla Ltd. Peptides and Heparin Product and Services
2.1.4 Cipla Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Emcure Pharmaceuticals Pvt. Ltd.
2.2.1 Emcure Pharmaceuticals Pvt. Ltd. Details
2.2.2 Emcure Pharmaceuticals Pvt. Ltd. Major Business
2.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Product and Services
2.2.4 Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Gland Pharma Limited
2.3.1 Gland Pharma Limited Details
2.3.2 Gland Pharma Limited Major Business
2.3.3 Gland Pharma Limited Peptides and Heparin Product and Services
2.3.4 Gland Pharma Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Troikaa Pharmaceuticals Ltd.
2.4.1 Troikaa Pharmaceuticals Ltd. Details
2.4.2 Troikaa Pharmaceuticals Ltd. Major Business
2.4.3 Troikaa Pharmaceuticals Ltd. Peptides and Heparin Product and Services
2.4.4 Troikaa Pharmaceuticals Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Biological E Limited
2.5.1 Biological E Limited Details
2.5.2 Biological E Limited Major Business
2.5.3 Biological E Limited Peptides and Heparin Product and Services
2.5.4 Biological E Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Bharat Biotech
2.6.1 Bharat Biotech Details
2.6.2 Bharat Biotech Major Business
2.6.3 Bharat Biotech Peptides and Heparin Product and Services
2.6.4 Bharat Biotech Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Samarth Life Sciences Pvt. Ltd.
2.7.1 Samarth Life Sciences Pvt. Ltd. Details
2.7.2 Samarth Life Sciences Pvt. Ltd. Major Business
2.7.3 Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Product and Services
2.7.4 Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 VHB Life Sciences Limited
2.8.1 VHB Life Sciences Limited Details
2.8.2 VHB Life Sciences Limited Major Business
2.8.3 VHB Life Sciences Limited Peptides and Heparin Product and Services
2.8.4 VHB Life Sciences Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Celon Laboratories Pvt. Ltd.
2.9.1 Celon Laboratories Pvt. Ltd. Details
2.9.2 Celon Laboratories Pvt. Ltd. Major Business
2.9.3 Celon Laboratories Pvt. Ltd. Peptides and Heparin Product and Services
2.9.4 Celon Laboratories Pvt. Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 United Biotech (P) Limited
2.10.1 United Biotech (P) Limited Details
2.10.2 United Biotech (P) Limited Major Business
2.10.3 United Biotech (P) Limited Peptides and Heparin Product and Services
2.10.4 United Biotech (P) Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Biocon Limited
2.11.1 Biocon Limited Details
2.11.2 Biocon Limited Major Business
2.11.3 Biocon Limited Peptides and Heparin Product and Services
2.11.4 Biocon Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Sun Pharmaceutical Industries Ltd.
2.12.1 Sun Pharmaceutical Industries Ltd. Details
2.12.2 Sun Pharmaceutical Industries Ltd. Major Business
2.12.3 Sun Pharmaceutical Industries Ltd. Peptides and Heparin Product and Services
2.12.4 Sun Pharmaceutical Industries Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Wockhardt Ltd.
2.13.1 Wockhardt Ltd. Details
2.13.2 Wockhardt Ltd. Major Business
2.13.3 Wockhardt Ltd. Peptides and Heparin Product and Services
2.13.4 Wockhardt Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Peptides and Heparin Sales by Manufacturer
3.1 Global Peptides and Heparin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Peptides and Heparin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Peptides and Heparin
3.4 Market Concentration Rate
3.4.1 Top 3 Peptides and Heparin Manufacturer Market Share
3.4.2 Top 6 Peptides and Heparin Manufacturer Market Share
3.5 Global Peptides and Heparin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Peptides and Heparin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Peptides and Heparin Market Size by Region
4.1.1 Global Peptides and Heparin Sales in Volume by Region (2016-2026)
4.1.2 Global Peptides and Heparin Revenue by Region (2016-2026)
4.2 North America Peptides and Heparin Revenue (2016-2026)
4.3 Europe Peptides and Heparin Revenue (2016-2026)
4.4 Asia-Pacific Peptides and Heparin Revenue (2016-2026)
4.5 South America Peptides and Heparin Revenue (2016-2026)
4.6 Middle East and Africa Peptides and Heparin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Peptides and Heparin Sales in Volume by Type (2016-2026)
5.2 Global Peptides and Heparin Revenue by Type (2016-2026)
5.3 Global Peptides and Heparin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Peptides and Heparin Sales in Volume by Application (2016-2026)
6.2 Global Peptides and Heparin Revenue by Application (2016-2026)
6.3 Global Peptides and Heparin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Peptides and Heparin Sales by Type (2016-2026)
7.2 North America Peptides and Heparin Sales by Application (2016-2026)
7.3 North America Peptides and Heparin Market Size by Country
7.3.1 North America Peptides and Heparin Sales in Volume by Country (2016-2026)
7.3.2 North America Peptides and Heparin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Peptides and Heparin Sales by Type (2016-2026)
8.2 Europe Peptides and Heparin Sales by Application (2016-2026)
8.3 Europe Peptides and Heparin Market Size by Country
8.3.1 Europe Peptides and Heparin Sales in Volume by Country (2016-2026)
8.3.2 Europe Peptides and Heparin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Peptides and Heparin Sales by Type (2016-2026)
9.2 Asia-Pacific Peptides and Heparin Sales by Application (2016-2026)
9.3 Asia-Pacific Peptides and Heparin Market Size by Region
9.3.1 Asia-Pacific Peptides and Heparin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Peptides and Heparin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Peptides and Heparin Sales by Type (2016-2026)
10.2 South America Peptides and Heparin Sales by Application (2016-2026)
10.3 South America Peptides and Heparin Market Size by Country
10.3.1 South America Peptides and Heparin Sales in Volume by Country (2016-2026)
10.3.2 South America Peptides and Heparin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Peptides and Heparin Sales by Type (2016-2026)
11.2 Middle East & Africa Peptides and Heparin Sales by Application (2016-2026)
11.3 Middle East & Africa Peptides and Heparin Market Size by Country
11.3.1 Middle East & Africa Peptides and Heparin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Peptides and Heparin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Peptides and Heparin Typical Distributors
12.3 Peptides and Heparin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Peptides and Heparin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Peptides and Heparin Revenue by Application, (USD Million), 2021-2026
Table 3. Cipla Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. Cipla Ltd. Major Business
Table 5. Cipla Ltd. Peptides and Heparin Product and Services
Table 6. Cipla Ltd. Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Emcure Pharmaceuticals Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 8. Emcure Pharmaceuticals Pvt. Ltd. Major Business
Table 9. Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Product and Services
Table 10. Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Gland Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 12. Gland Pharma Limited Major Business
Table 13. Gland Pharma Limited Peptides and Heparin Product and Services
Table 14. Gland Pharma Limited Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Troikaa Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 16. Troikaa Pharmaceuticals Ltd. Major Business
Table 17. Troikaa Pharmaceuticals Ltd. Peptides and Heparin Product and Services
Table 18. Troikaa Pharmaceuticals Ltd. Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Biological E Limited Basic Information, Manufacturing Base and Competitors
Table 20. Biological E Limited Major Business
Table 21. Biological E Limited Peptides and Heparin Product and Services
Table 22. Biological E Limited Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 24. Bharat Biotech Major Business
Table 25. Bharat Biotech Peptides and Heparin Product and Services
Table 26. Bharat Biotech Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Samarth Life Sciences Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Samarth Life Sciences Pvt. Ltd. Major Business
Table 29. Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Product and Services
Table 30. Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. VHB Life Sciences Limited Basic Information, Manufacturing Base and Competitors
Table 32. VHB Life Sciences Limited Major Business
Table 33. VHB Life Sciences Limited Peptides and Heparin Product and Services
Table 34. VHB Life Sciences Limited Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Celon Laboratories Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 36. Celon Laboratories Pvt. Ltd. Major Business
Table 37. Celon Laboratories Pvt. Ltd. Peptides and Heparin Product and Services
Table 38. Celon Laboratories Pvt. Ltd. Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. United Biotech (P) Limited Basic Information, Manufacturing Base and Competitors
Table 40. United Biotech (P) Limited Major Business
Table 41. United Biotech (P) Limited Peptides and Heparin Product and Services
Table 42. United Biotech (P) Limited Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Biocon Limited Basic Information, Manufacturing Base and Competitors
Table 44. Biocon Limited Major Business
Table 45. Biocon Limited Peptides and Heparin Product and Services
Table 46. Biocon Limited Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 48. Sun Pharmaceutical Industries Ltd. Major Business
Table 49. Sun Pharmaceutical Industries Ltd. Peptides and Heparin Product and Services
Table 50. Sun Pharmaceutical Industries Ltd. Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Wockhardt Ltd. Basic Information, Manufacturing Base and Competitors
Table 52. Wockhardt Ltd. Major Business
Table 53. Wockhardt Ltd. Peptides and Heparin Product and Services
Table 54. Wockhardt Ltd. Peptides and Heparin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Peptides and Heparin Sales by Manufacturer (2019-2021e) & (K MT)
Table 56. Global Peptides and Heparin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Peptides and Heparin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Peptides and Heparin Production Capacity by Company, (K MT): 2020 VS 2021
Table 59. Head Office and Peptides and Heparin Production Site of Key Manufacturer
Table 60. Global Peptides and Heparin Sales by Region (2016-2021e) & (K MT)
Table 61. Global Peptides and Heparin Sales by Region (2021-2026) & (K MT)
Table 62. Global Peptides and Heparin Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Peptides and Heparin Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Peptides and Heparin Sales by Type (2016-2021e) & (K MT)
Table 65. Global Peptides and Heparin Sales by Type (2021-2026) & (K MT)
Table 66. Global Peptides and Heparin Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Peptides and Heparin Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Peptides and Heparin Price by Type (2016-2021e) & (USD/MT)
Table 69. Global Peptides and Heparin Price by Type (2021-2026) & (USD/MT)
Table 70. Global Peptides and Heparin Sales by Application (2016-2021e) & (K MT)
Table 71. Global Peptides and Heparin Sales by Application (2021-2026) & (K MT)
Table 72. Global Peptides and Heparin Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Peptides and Heparin Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Peptides and Heparin Price by Application (2016-2021e) & (USD/MT)
Table 75. Global Peptides and Heparin Price by Application (2021-2026) & (USD/MT)
Table 76. North America Peptides and Heparin Sales by Country (2016-2021e) & (K MT)
Table 77. North America Peptides and Heparin Sales by Country (2021-2026) & (K MT)
Table 78. North America Peptides and Heparin Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Peptides and Heparin Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Peptides and Heparin Sales by Type (2016-2021e) & (K MT)
Table 81. North America Peptides and Heparin Sales by Type (2021-2026) & (K MT)
Table 82. North America Peptides and Heparin Sales by Application (2016-2021e) & (K MT)
Table 83. North America Peptides and Heparin Sales by Application (2021-2026) & (K MT)
Table 84. Europe Peptides and Heparin Sales by Country (2016-2021e) & (K MT)
Table 85. Europe Peptides and Heparin Sales by Country (2021-2026) & (K MT)
Table 86. Europe Peptides and Heparin Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Peptides and Heparin Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Peptides and Heparin Sales by Type (2016-2021e) & (K MT)
Table 89. Europe Peptides and Heparin Sales by Type (2021-2026) & (K MT)
Table 90. Europe Peptides and Heparin Sales by Application (2016-2021e) & (K MT)
Table 91. Europe Peptides and Heparin Sales by Application (2021-2026) & (K MT)
Table 92. Asia-Pacific Peptides and Heparin Sales by Region (2016-2021e) & (K MT)
Table 93. Asia-Pacific Peptides and Heparin Sales by Region (2021-2026) & (K MT)
Table 94. Asia-Pacific Peptides and Heparin Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Peptides and Heparin Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Peptides and Heparin Sales by Type (2016-2021e) & (K MT)
Table 97. Asia-Pacific Peptides and Heparin Sales by Type (2021-2026) & (K MT)
Table 98. Asia-Pacific Peptides and Heparin Sales by Application (2016-2021e) & (K MT)
Table 99. Asia-Pacific Peptides and Heparin Sales by Application (2021-2026) & (K MT)
Table 100. South America Peptides and Heparin Sales by Country (2016-2021e) & (K MT)
Table 101. South America Peptides and Heparin Sales by Country (2021-2026) & (K MT)
Table 102. South America Peptides and Heparin Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Peptides and Heparin Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Peptides and Heparin Sales by Type (2016-2021e) & (K MT)
Table 105. South America Peptides and Heparin Sales by Type (2021-2026) & (K MT)
Table 106. South America Peptides and Heparin Sales by Application (2016-2021e) & (K MT)
Table 107. South America Peptides and Heparin Sales by Application (2021-2026) & (K MT)
Table 108. Middle East & Africa Peptides and Heparin Sales by Country (2016-2021e) & (K MT)
Table 109. Middle East & Africa Peptides and Heparin Sales by Country (2021-2026) & (K MT)
Table 110. Middle East & Africa Peptides and Heparin Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Peptides and Heparin Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Peptides and Heparin Sales by Type (2016-2021e) & (K MT)
Table 113. Middle East & Africa Peptides and Heparin Sales by Type (2021-2026) & (K MT)
Table 114. Middle East & Africa Peptides and Heparin Sales by Application (2016-2021e) & (K MT)
Table 115. Middle East & Africa Peptides and Heparin Sales by Application (2021-2026) & (K MT)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Peptides and Heparin Typical Distributors
Table 119. Peptides and Heparin Typical Customers
List of Figures
Figure 1. Peptides and Heparin Picture
Figure 2. Global Peptides and Heparin Sales Market Share by Type in 2020
Figure 3. Insulin
Figure 4. Teriparatide
Figure 5. Liraglutide
Figure 6. Leuprolide
Figure 7. Leuprolide
Figure 8. Exenatide
Figure 9. Calcitonin
Figure 10. Enaxaparin Sodium
Figure 11. Heparin Sodium
Figure 12. Global Peptides and Heparin Sales Market Share by Application in 2020
Figure 13. Diabetes
Figure 14. Infectious Diseases
Figure 15. Cancer
Figure 16. Osteoporosis
Figure 17. Global Peptides and Heparin Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 18. Global Peptides and Heparin Market Size and Forecast (2016-2026) & (USD Million)
Figure 19. United States Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Canada Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Mexico Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Germany Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. France Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. United Kingdom Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Russia Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Italy Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. China Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Japan Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Korea Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. India Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Southeast Asia Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Australia Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Brazil Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Egypt Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Saudi Arabia Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. South Africa Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Turkey Peptides and Heparin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Global Peptides and Heparin Sales (2016-2026) & (K MT)
Figure 39. Global Peptides and Heparin Production Capacity (2016-2026) & (K MT)
Figure 40. Global Peptides and Heparin Production Capacity by Geographic Region: 2020 VS 2021
Figure 41. Peptides and Heparin Market Drivers
Figure 42. Peptides and Heparin Market Restraints
Figure 43. Peptides and Heparin Market Trends
Figure 44. Global Peptides and Heparin Sales Market Share by Manufacturer in 2020
Figure 45. Global Peptides and Heparin Revenue Market Share by Manufacturer in 2020
Figure 46. Peptides and Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 47. Top 3 Peptides and Heparin Manufacturer (Revenue) Market Share in 2020
Figure 48. Top 6 Peptides and Heparin Manufacturer (Revenue) Market Share in 2020
Figure 49. Global Peptides and Heparin Sales Market Share by Region (2016-2026)
Figure 50. Global Peptides and Heparin Revenue Market Share by Region (2016-2026)
Figure 51. North America Peptides and Heparin Revenue (2016-2026) & (USD Million)
Figure 52. Europe Peptides and Heparin Revenue (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Peptides and Heparin Revenue (2016-2026) & (USD Million)
Figure 54. South America Peptides and Heparin Revenue (2016-2026) & (USD Million)
Figure 55. Middle East & Africa Peptides and Heparin Revenue (2016-2026) & (USD Million)
Figure 56. Global Peptides and Heparin Sales Market Share by Type (2016-2026)
Figure 57. Global Peptides and Heparin Revenue Market Share by Type (2016-2026)
Figure 58. Global Peptides and Heparin Price by Type (2016-2026) & (USD/MT)
Figure 59. Global Peptides and Heparin Sales Market Share by Application (2016-2026)
Figure 60. Global Peptides and Heparin Revenue Market Share by Application (2016-2026)
Figure 61. Global Peptides and Heparin Price by Application (2016-2026) & (USD/MT)
Figure 62. North America Peptides and Heparin Sales Market Share by Country (2016-2026)
Figure 63. North America Peptides and Heparin Revenue Market Share by Country (2016-2026)
Figure 64. North America Peptides and Heparin Sales Market Share by Type (2016-2026)
Figure 65. North America Peptides and Heparin Sales Market Share by Application (2016-2026)
Figure 66. Europe Peptides and Heparin Sales Market Share by Country (2016-2026)
Figure 67. Europe Peptides and Heparin Revenue Market Share by Country (2016-2026)
Figure 68. Europe Peptides and Heparin Sales Market Share by Type (2016-2026)
Figure 69. Europe Peptides and Heparin Sales Market Share by Application (2016-2026)
Figure 70. Asia-Pacific Peptides and Heparin Sales Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Peptides and Heparin Revenue Market Share by Region (2016-2026)
Figure 72. Asia-Pacific Peptides and Heparin Sales Market Share by Region (2016-2026)
Figure 73. Asia-Pacific Peptides and Heparin Sales Market Share by Application (2016-2026)
Figure 74. South America Peptides and Heparin Sales Market Share by Country (2016-2026)
Figure 75. South America Peptides and Heparin Revenue Market Share by Country (2016-2026)
Figure 76. South America Peptides and Heparin Sales Market Share by Type (2016-2026)
Figure 77. South America Peptides and Heparin Sales Market Share by Application (2016-2026)
Figure 78. Middle East & Africa Peptides and Heparin Sales Market Share by Country (2016-2026)
Figure 79. Middle East & Africa Peptides and Heparin Revenue Market Share by Country (2016-2026)
Figure 80. Middle East & Africa Peptides and Heparin Sales Market Share by Type (2016-2026)
Figure 81. Middle East & Africa Peptides and Heparin Sales Market Share by Application (2016-2026)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
世界のヘパリンAPI市場 2021：企業別、地域別、種類・用途別 The Heparin API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent…- 世界のヘパリン有効成分市場 2021：企業別、地域別、種類・用途別 The Heparin Active Pharmaceutical Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界のペプチド市場 2021：企業別、地域別、種類・用途別 The Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent de…
- 世界の糖尿病用非インスリン療法市場 2021：企業別、地域別、種類・用途別 The Non-Insulin Therapies for Diabetes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界のトリフルオロメタンスルホン酸ナトリウム市場 2021：企業別、地域別、種類・用途別 The Sodium Trifluoromethanesulfonate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…